Become a Patron!

Barclays Adjusts Valuation Targets for Iovance Biotherapeutics (IOVA) Amid Biotech Sector Review

Status
Not open for further replies.

VUBot

Staff member
Diamond Contributor
ECF Refugee
Vape Media
e56c487dc9aa9d27_sq.webp


Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best biotech penny stocks to buy according to analysts. On December 17, Barclays analyst Etzer Darout raised the firm’s price target on Iovance Biotherapeutics to $10 from $9, while keeping an Overweight rating on the shares. This…

Continue reading...
 
Status
Not open for further replies.

VU Sponsors

Top